IL6 and neoplasm: Mechanistically, ALI may affect prognosis through two pathways: firstly, high NLR reflects systemic inflammation, which promotes the release of pro-inflammatory cytokines (such as IL-6, TNF-α) and drives tumor invasion via the STAT3 pathway (49, 50).